VILINBIO2025-01-012025-03-31VILINBIO2025-03-31VILINBIO2024-12-31VILINBIO2025-03-31ImpositionOfFineOrPenaltyDomain1xbrli:pure000000VILINBIONOTLISTEDINE0L4V01013VILIN BIO MED LIMITED2024-04-012025-03-31Yearly2025-03-31SMEfalseIn pursuant to Regulation 15 of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, the compliance with respect to the corporate governance provisions as specified in Regulation 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26, 27 and clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46 and Para C, D and E of Schedule V shall not apply, in respect of a listed entity: a. Having paid up equity share capital not exceeding rupees ten crore and net worth not exceeding rupees twenty-five crore, as on the last day of previous financial year. b. Which has listed its specified securities on the SME Exchange. Please be informed that Vilin Bio Med Limited ("the Company") has listed its specified securities on the SME Platform of the NSE (NSE EMERGE), and as per the Exemption provided under Regulation 15(2)(b) of the SEBI (LODR) Regulations, 2015, the above said LODR Regulations as mentioned in Para 01 are not applicable to us for the Half year ended March 31, 2025 and year ended 31st March 2025. truefalsePlease be informed that Vilin Bio Med Limited ("the Company") has not acquired any shares or voting rights in any unlisted entity as on March 31,2025. So the Annexure I Part C of the SEBI Circular Dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in a Unlisted Company is not applicable to the entitytruefalsePlease be informed that Vilin Bio Med Limited ("the Company") has got no ongoing Tax Litigations or Disputes as on March 31,2025..So the Annexure I Part E of the SEBI Circular Dated December 31, 2024 related to Disclosure of updates to Ongoing Tax Litigations or Disputes is not applicable to the entityfalsePlease be informed that Vilin Bio Med Limited ("the Company") has got no default in any loans/guarantees/ comfort letters/securities etc. as on March 31,2025..So the Annexure I Part E of the SEBI Circular Dated December 31, 2024 related to Disclosure of loans/guarantees/ comfort letters/securities etc is not applicable to the entitytrueCOMV00471Original00000NATIONAL STOCK EXCHANGEFINE HAS BEEN IMPOSED FOR NON COMPLIANCE WITH SEBI(LODR) REGULATIONS 2015 AND/OR REG 76 OF SEBI(DEPOSITORY PARTICIPANT) REGULATIONS 20182025-02-20NON COMPLIANCE WITH SEBI(LODR) REGULATIONS 2015 AND/OR REG 76 OF SEBI(DEPOSITORY PARTICIPANT) REGULATIONS 2018Rs. 33040/-